Week 368 Review - Disaster as Optibiotix share price collapses

This has been my worst week ever. Nearly everything dropped, but OPTI:Optibiotix dropped 10.75p to the lowest it has been since I have been a shareholder. That and everything else falling, increased the deficit between cost and value by £23,280 to £103,560 and smashed the overall value down to £76,239.

Worst performer by far was OPTI:Optibiotix, with the 10.75p drop being 19% of a £100k holding. I was in a state of shock for some time after reading the pitiful trading update. There are reasons why it was so bad, and I still think we'll make it in the long run, but my confidence was severely rocked.

AJB:AJ Bell had been doing well lately, but dropped 9% for no particular reason and has gone from 4% profit to 5% loss.

JLP:Jubilee Metals has been sinking like a stone and dropped another 6% this week which was enough to make me sell the whole lot so I could preserve my profits. I'll buy back once the current seller is finished. The suspicion is that someone with cheap warrants is offloading them as there are million+ sells every day.

PLUS:Plus500 is doing the same as AJB:AJ Bell and dropped 6% but at least these are still 7% up. I am slightly worried though, as when these went above 10^% up I added a virtual stop loss. They went to 13% up so if I follow my new rules I will sell when they go down to 3% profit. I really hope I don't have to trigger that, but I have already qualified for the next dividend and I could always buy them back later.

SBTX:SkinBioTherapeutics seemed to fall in sympathy with OPTI:Optibiotix and dropped another 6% to go 55% down. All my microbiome shares are a disaster.

Just as I had a sense of optimism that things were turning around, this is a devastating blow.

Back below the trend line and over £100k down. What an absolute nightmare.

Here's the ISA and shares portfolio after week 4 of year 8.

			Weekly Change
Cash	£1,821.33		+£1,811.09
Portfolio cost	£80,192.06		-£593.00
Portfolio sell value (bid price-commission)	£30,049.73	(-62.5%)	-£12,259.56
Potential profits	£0		-£1,312.05
Yr 8 Dividends	£0		+£0
Yr 8 Profit from sales	-£995.63		+£1,218.09
Yr 8 projected avg monthly profit	-£1,078.60	(-29.2%)	+£2,119.00
Total Dividends	£11,768.92		+£0
Total Profit from sales	£27,098.43		+£1,218.09
Average monthly cash profit	£453.83	(12.3%)	+£13.14
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	87%		+3%

Huge increase in cash after selling JLP:Jubilee Metals. I sold my 13,500 shares for 13.504p and made £1,218.09 (201.3%) profit. It repaired some of the damage from selling TLOU:Tlou Energy at such a big loss but means nothing is anywhere near in profit now. My plan is to buy back into JLP when the seller finishes.

Worst ever decline in portfolio value in one week means it has lost 62.5% of its value. I'm still finding it hard to believe. So much optimism a few weeks ago after the Firmenich announcement and now this. Deeply distressing.

Disaster

More disaster

The SIPP looks like this after week 352 overall and week 40 of year 7.

			Weekly Change
Cash	£141.54		+£65.00
Portfolio cost	£95,724.27		+£0
Portfolio sell value (bid price - commission)	£43,466.19	(-54.6%)	-£11,686.57
Potential profits	£95.35		-£136.75
Yr 7 Dividends	£10,727.13		+£0
Yr 7 Interest	£0.01		+£0
Yr 7 Profit from sales	-£3,290.88		+£0
Yr 7 projected avg monthly profit	£790.29	(16.7%)	-£20.26
Total Dividends	£13,931.52		+£0
Total Interest	£0.21		+£0
Total Profit from sales	£20,433.75		+£0
Average monthly cash profit	£411.20	(8.7%)	-£1.17
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	59%		+0%

Cash went up thanks to a tax refund, and same disastrous drop in value. Potential profits also plummeted by £136 as all my profitable shares tanked. 

Not lowest in last 12 months but not far off

Back below the trend line.

The trading account looks like this after week 318 overall and week 6 of year 7.

			Weekly Change
Cash	£43.18		+£0
Portfolio cost	£1,877.84		+£0
Portfolio sell value (bid price - commission)	£717.52	(-61.8%)	-£27.82
Potential profits	£0.00		+£0
Year 7 Dividends	£0.00		+£0
Year 7 Profit	£0.00		+£0
Yr 7 projected avg monthly profit	£0.00	(0.0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£226.60		+£0
Average monthly cash profit	£3.91	(2.5%)	-£0.01
(Sold stocks profit + Dividends - Fees / Months)

JLP:Jubilee Metals dropped this week so I lost £27 value. My virtual stop loss is placed at 12.8p and it's only on 13.4p so could easily trigger next week given the seller. I will be strict in applying it to this account. With my new tactics I would never have picked JLP for this account.

The creeping rise was short lived

I may get a flat trend line on this one. Mind you, given 75% of the shares are suspended it may as well be completely flat.

Can't write any more. Way too miserable to be interested.

Week 367 Review - Sold out of Tlou Energy at a loss

This was a relatively flat week with few movers, but I did take some fairly hefty losses when I sold TLOU:Tlou Energy, so although the deficit between cost and value improved by £2,460 to £80,179, the portfolio value dropped by about £500 to £98,337.

APAX:Apax Global Alpha dropped 5% after a really good run and is unfortunately back at a loss being 3% down.

CAML:Central Asia Metals also dropped 5% and is now only 3% up.

Share of the Week is PLUS:Plus500 which responded nicely to good results by climbing 6% and is now 13% in profit. This gives me a chance to implement my new virtual trailing stop-loss which I put 10% below my profits once they go above 10%. So if these drop down to 3% profit I will sell them. If they go up, then my trailing stop will go up too, so I never let them drop more than 10% without selling.

For new shares I will set my virtual trailing stop loss at -15% but it will stay there until they are at 10% profit, at which point it moves to 0% so I at least avoid selling at a loss.

Still below the injection line

A small tick up after taking the loss from TLOU:Tlou Energy

Here's the ISA and shares portfolio after week 3 of year 8.

			Weekly Change
Cash	£10.24		-£86.01
Portfolio cost	£80,785.06		-£2,127.71
Portfolio sell value (bid price-commission)	£42,309.29	(-47.6%)	-£317.74
Potential profits	£1,312.05		+£0
Yr 8 Dividends	£0		+£0
Yr 8 Profit from sales	-£2,213.72		-£2,213.72
Yr 8 projected avg monthly profit	-£3,197.60	(-86.6%)	-£3,197.60
Total Dividends	£11,768.92		+£0
Total Profit from sales	£25,880.34		-£2,213.72
Average monthly cash profit	£440.69	(11.9%)	-£27.41
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	84%		-5%

Big loss of £2,213 from selling TLOU:Tlou Energy. I sold after watching the BBC series Big Oil vs The World. There were two reasons. The first was the realisation of how bad methane production was for contributing to global warming. I had no idea how much methane leakage there was. The second was a purely financial fear that by the time the transmission line is complete, methane production will be so frowned upon that the whole thing will go bust.

I sold my 40,000 shares at 1.788p making at loss of £2,213.72 (-75.7%). Absolute disaster, but it did liberate £703 so I bought 2,601 shares in OPTI:Optibiotix at 29.885p costing £789.26.

Performance was hammered by the sale, particularly year 8 performance as we're still in the first month. Long term performance remains above 10% thanks to the PBX:Probiotix dividend.

Potential profits remained flat as JLP:Jubilee Metals didn't move. They are still up 217% and I've set my virtual stop loss at 200% so if they drop much further I'll sell.

Steep drop in cost while value fairly flat and well below the injection line.

Sharp tick upwards as the deficit improved after taking the loss.

The SIPP looks like this after week 351 overall and week 39 of year 7.

			Weekly Change
Cash	£76.54		-£6.13
Portfolio cost	£95,724.27		-£785.23
Portfolio sell value (bid price - commission)	£55,152.76	(-42.4%)	-£134.53
Potential profits	£232.10		-£85.71
Yr 7 Dividends	£10,727.13		+£0
Yr 7 Interest	£0.01		+£0
Yr 7 Profit from sales	-£3,290.88		-£1,139.10
Yr 7 projected avg monthly profit	£810.55	(17.1%)	-£151.30
Total Dividends	£13,931.52		+£0
Total Interest	£0.21		+£0
Total Profit from sales	£20,433.75		-£1,139.10
Average monthly cash profit	£412.37	(8.7%)	-£15.29
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	59%		-2%

Same story here as I sold my TLOU:Tlou Energy holding of 80,000 shares at 1.785p making a loss of £1,139.10 (44.8%). I also re-invested the proceeds in OPTI:Optibiotix buying 4,769 shares at 29.885p costing £1,437.17. When I added up my holding it was really close to 200,000 so I added some cash to my AJ Bell SIPP and bought another 1,076 at 30p costing £332,75 and reaching an unexpected and absolutely stunning milestone.

Performance was dented but not too badly, and my biggest losses this week were in profitable shares so potential profits dropped by £85 to £232.

Not as far below the injection line as the ISA

Less of a tick up, but we're starting to flatten the trend line a little.

The trading account looks like this after week 317 overall and week 5 of year 7.

			Weekly Change
Cash	£43.18		+£0
Portfolio cost	£1,877.84		+£0
Portfolio sell value (bid price - commission)	£745.34	(-60.3%)	+£0
Potential profits	£0.00		+£0
Year 7 Dividends	£0.00		+£0
Year 7 Profit	£0.00		+£0
Yr 7 projected avg monthly profit	£0.00	(0.0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£226.60		+£0
Average monthly cash profit	£3.92	(2.5%)	-£0.01
(Sold stocks profit + Dividends - Fees / Months)

Virtually nothing happened, with JLP:Jubilee Metals staying flat and long term performance down by 1p.

Flat but still dreadful

I do believe that trend line is getting flatter!

No time to write any more, just feeling happy to have hit the 200,000 shares in OPTI:Optibiotix milestone, which takes away some of the misery of my TLOU:Tlou Energy loss.

Week 366 Review - Four down weeks in a row

Another drop in value for the 4th week in a row, but all down to a 1p fall in OPTI:Optibiotix which cost £1,900, with some good performances elsewhere. The deficit between cost and value widened by £1,631 to £82,640 and overall value dropped below £100k to £98,869.

No big percentage fallers this week, with OPTI:Optibiotix only dropping 2% but still costing lots

AJB:AJ Bell has been a good choice for magic formula share, climbing 7% this week to go into profit and 5% up.

Share of the Week is APAX:Apax Global Alpha which went up 9% and  is now 2% in profit. I only invested £500 over 4 months of monthly savings but I will probably hang onto them if they stay in profit.

Back below he injection line

Still well above the tend line but heading downwards in parallel with it.

Here's the ISA and shares portfolio after week 2 of year 8.

			Weekly Change
Cash	£96.25		+£0
Portfolio cost	£82,912.77		+£0
Portfolio sell value (bid price-commission)	£42,627.03	(-48.6%)	-£861.06
Potential profits	£1,312.05		+£27.00
Yr 8 Dividends	£0		+£0
Yr 8 Profit from sales	£0		+£0
Yr 8 projected avg monthly profit	£0	(0%)	+£0
Total Dividends	£11,768.92		+£0
Total Profit from sales	£28,094.06		+£0
Average monthly cash profit	£468.10	(12.7%)	-£1.28
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	89%		+0%

A relatively quiet week. A small increase in JLP:Jubilee Metals increased potential profits by £27 and the £861 drop is mostly OPTI:Optibiotix. The only other glimmer of hope was RDT:Rosslyn Data climbing 3%. but they are still 91% down so I don't hold out much hope.

Steady decline for 4 weeks.

The decline is steeper than the trend line, so not at all good.

The SIPP looks like this after week 350 overall and week 38 of year 7.

			Weekly Change
Cash	£71.41		-£124.49
Portfolio cost	£96,509.50		-£124.49
Portfolio sell value (bid price - commission)	£55,287.29	(-42.7%)	-£776.98
Potential profits	£317.81		+£20.32
Yr 7 Dividends	£10,727.13		+£0
Yr 7 Interest	£0.01		+£0
Yr 7 Profit from sales	-£2,151.78		+£0
Yr 7 projected avg monthly profit	£961.85	(20.4%)	-£25.99
Total Dividends	£13,931.52		+£0
Total Interest	£0.21		+£0
Total Profit from sales	£21,572.85		+£0
Average monthly cash profit	£427.66	(9.1%)	-£1.22
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	61%		+0%

The £124 was my monthly savings investment, this time onto EMG:Man Group. That went through the day before ex-dividend date, so I'll get my dividend on £523 worth of shares when you add what I bought last week. They were up 4% this week and so are now only £2 in the red.

Potential profits only climbed £20 but that masks the fact that two magic formula shares (APAX:Apax Global Alpha and AJB:AJ Bell) went into profit and PLUS:Plus500 increased potential profits by 2%. Unfortunately a 3% drop in CAML:Central Asia Metals wiped most of that out.

Only just below the injection line

Unlike the ISA, this is more shallow than the trend line, but still downwards.

The trading account looks like this after week 316 overall and week 4 of year 7.

			Weekly Change
Cash	£43.18		+£0
Portfolio cost	£1,877.84		+£0
Portfolio sell value (bid price - commission)	£745.34	(-60.3%)	+£6.95
Potential profits	£0.00		+£0
Year 7 Dividends	£0.00		+£0
Year 7 Profit	£0.00		+£0
Yr 7 projected avg monthly profit	£0.00	(0.0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£226.60		+£0
Average monthly cash profit	£3.93	(2.5%)	-£0.01
(Sold stocks profit + Dividends - Fees / Months)

A tiny increase in JLP:Jubilee Metals which will hopefully take some momentum into next week so I can get into potential profit.

Unlike the others this is very slowly sneaking upwards, but like the others it is below the injection line.

Slow and steady.

Another week goes by with no news on Sweetbiotix product launches or anything on LP-LDL. We're well into summer holiday territory now so I may as well stop thinking about it until September.

Week 365 Review - Big losses realised in SIPP clear-out

I had a big clear-out of duffer stocks from the SIPP and took around £2,500 of losses, which immediately benefited the deficit between cost and value but hammered my performance stats. Unfortunately a 2.5p drop in OPTI:Optibiotix cost around £4,700 so I still had a widening gap between cost and value by £2,156 with my third down week in a row. The deficit is now £81,009 and total portfolio value just stayed above £100k at £100,500.

There were no big fallers this week, at least in terms of 5% or more, as even OPTI:Optibiotix only dropped 4%.

APAX:Apax Global Alpha has been my monthly SIPP investment for the last 4 months, although I've stopped it now as it doesn't qualify based on my new system. My small holding went up by 6% this week and is only 7% down now. I'll hold these because it is in my top 30 magic formula shares, but is in a downward momentum which would now stop me buying. I'll certainly exercise my new 15% virtual stop loss if they should fall further, which they got very close to last week.

CEY:Centamin seems to be staging a bit of a recovery, with reasonable results this week and a 6% climb in share price. They are still 23% down so a long way till break even.

Share of the Week is JLP:Jubilee Metals which went up 7% of my original purchase price. As that's only a small percentage of the current price I wouldn't normally give it Share of the Week, but I'm feeling positive about it at the moment and hopefully my holding in the trading account will get into profit soon so I can try and resurrect the fortunes of that account.

Rather painfully the combined portfolio value has dropped back below the injection line

Following the same angle as the trend line, but at least still above it

Here's the ISA and shares portfolio after week 1 of year 8.

			Weekly Change
Cash	£96.25		-£3.75
Portfolio cost	£82,912.77		+£0
Portfolio sell value (bid price-commission)	£43,488.09	(-47.5%)	-£2,318.31
Potential profits	£1,285.05		+£40.50
Yr 8 Dividends	£0		+£0
Yr 8 Profit from sales	£0		+£0
Yr 8 projected avg monthly profit	£0	(0%)	+£0
Total Dividends	£11,768.92		+£0
Total Profit from sales	£28,094.06		+£0
Average monthly cash profit	£469.38	(12.7%)	-£1.34
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	89%		+0%

Cash went down due to monthly ISA fee and most of the damage to portfolio value was the drop in OPTI:Optibiotix. Potential profits went up £40 thanks to JLP:Jubilee Metals, and we start year 8 so all the annual stats re-set.

Back below the injection line

Dropping steeper than the trend line

The SIPP looks like this after week 349 overall and week 37 of year 7.

			Weekly Change
Cash	£194.90		+£91.17
Portfolio cost	£96,385.01		-£2,004.92
Portfolio sell value (bid price - commission)	£55,939.78	(-42.0%)	-£1,853.23
Potential profits	£297.49		+£60.77
Yr 7 Dividends	£10,727.13		+£0
Yr 7 Interest	£0.01		+£0
Yr 7 Profit from sales	-£2,151.78		-£2,427.09
Yr 7 projected avg monthly profit	£987.84	(21.0%)	-£321.60
Total Dividends	£13,931.52		+£0
Total Interest	£0.21		+£0
Total Profit from sales	£21,572.85		-£2,427.09
Average monthly cash profit	£428.88	(9.1%)	-£31.67
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	61%		-5%

A lot happened this week!

I'm reading a book and it's been quite inspirational. "Trade like a stock market wizard" by Mark Minervini had already made me change my magic formula ranking to use 3-year growth rather than P/E ratio, the reasoning being that the "cheapness" of a share is meaningless if the company is growing. You can buy an expensive share and it can still go up.

It was when I got to the section about getting out of losing stocks quickly that I had a change of mind-set. Several other books have said the same thing but I never really bought into the concept. This book stated it differently. The author reckoned 50-60% of his trades were loss making, but that by limiting those losses to around 10% and letting the profitable shares climb much higher, he saved himself taking big losses and watching his capital tied up in failing companies for years.

That's where I'm at. Nearly all my companies are failing, but I'm in such deep losses that I won't accept defeat and spend every week watching the losses deepen, or at the best stagnate. The complete failure of the trading account shines a light on what is happening all across my portfolio.

So I decided to have a bit of a clear out in the SIPP. Granted I should have cleared out a long time ago and would have only been nursing around £500 of losses, but I waited until now and so suffered around £2,500 losses.

The first share to go was HUM:Hummingbird Resources. They are spending way more producing gold than they can sell it for, and there's no sign of that improving. An absolute disaster of a company and one I wouldn't have gone near if I wasn't stupid enough to read bulletin boards and believe the rubbish spouted on them. I sold my 1,538 shares for 7.7456p taking a loss of £404.62 (77.3%) but at least liberated £107 from a company that will probably go bust. I'm just glad it was a very small toe-dip investment.

The next to go was IQE:IQE. I bought them on a wave of optimism that they would lead the world in making wafers for micro-chips, and I did really well in their early rise making £7,116 profit. However I bought back in at the peak of their share price which promptly plummeted on the back of the Muddywaters report of dodgy accounting and what has now become a company spending more on producing their product than they get back for selling it. I sold my 1,809 shares for 43.901p taking a loss of £1,607.66 (67%) but at least liberated £782. I guess I'm still up over £5,000 from my IQE holdings so shouldn't grumble too  much.

The other 2 shares I cleared out were both magic formula shares that are in decline and so would not qualify to be bought now.

The first is ASY:Andrews Sykes Group which has been stagnant for years, so although paying a reasonable dividend they are unlikely to go up in price, as they haven't managed it for the last few years. I sold my 176 shares at 492p and took a loss of £154.66 (15.2%). My new rule is to put in place a virtual stop loss of 15% which basically gives you 10% on price drop and 5% to cover spread and commission. The sale liberated £853.

The final sale was ASHM:Ashmore Group. They have been declining steadily for years, and I've been concerned about their exposure to Evergrande bonds for a while. I sold my 358 shares at 214.299p and took a loss of £260.15 (25%). That liberated £755.

So although I took some hefty losses, I liberated a total of £2,498 that had been stuck in loss making shares for a long time - years in the case of IQE. I can hopefully re-deploy the money where it can make some profit.

There are other shares that have declined much more than these, but they have gone way past the point of selling because the benefit of getting the tiny return back isn't worth the cost of the losses. I may have to hold them for 15 years before they go bust or break even, but I may as well because there's nothing worth getting back just now.

I decided to get one new magic formula share, and went through my top 30 list looking for ones whose share price was growing. The one I picked was NUM:Numis Corp. They had been on a pretty steady climb for years until peaking around spring 2021 and going into a gradual decline until February this year. For the last 3 months they have been steadily increasing, and the key for me was the opening of their Dublin office which gives them access to EU markets. They are also doing share buy-backs at the moment which is sensible seeing as they are on a P/E ratio of 5 (not that it came into my consideration when ranking the stock).

I bought 374 shares at 266.75p costing £1,009.60 and they went up to 269p so I'm only 2% down which is less than the commission. If they drop by 15% I will sell them.

I couldn't help myself with the other £1,500. I bought 4,591 shares in OPTI:Optibiotix at 32.67p costing £1,511.83. I'm still as convinced as I have ever been that everything about this company is about to lead to a massive re-rate. It happened 6 years ago prematurely and I should have seen that there was a long way to go before the market would be convinced by a new science like this. However, once the market sees what's coming with Sweetbiotix and microbiome modulators, they will be flocking to buy the shares. I know this has been a disaster of an investment so far, but that's down to the timing of my purchases, not the performance of the company. The purchase took my holding to over 190,000 shares.

That's not the end of it. I switched my monthly saving from APAX:Apax Global Alpha to EMG:Man Group which have been on a long term climb in share price since late 2020, but which took a nose-dive following their recent interims. I think they'll get back on their trajectory, and they also go ex-dividend next week so I added £400 to my AJ Bell SIPP and bought 164 shares at 237.45p costing £399.37. When my £130 is automatically invested next week, I will have a nice £500 invested and an instant dividend.

The effect of all that and the 4% drop in OPTI:Optibiotix meant a drop in value of £1,853 but an improvement in the deficit between cost and value of £151. Annual performance was hammered by £321 a month and long term performance to a £31 a month hit and dropped from 9.9% to 9.1%.

Potential profits went up by £60 as both CAML:Central Asia Metals and PLUS:Plus500 had positive weeks.

The value line has dipped below the injection line, but only by £300

The deficit between cost and value actually improved a tiny amount thanks to taking the loss

The trading account looks like this after week 315 overall and week 3 of year 7.

			Weekly Change
Cash	£43.18		+£0
Portfolio cost	£1,877.84		+£0
Portfolio sell value (bid price - commission)	£738.39	(-60.7%)	+£10.44
Potential profits	£0.00		+£0
Year 7 Dividends	£0.00		+£0
Year 7 Profit	£0.00		+£0
Yr 7 projected avg monthly profit	£0.00	(0.0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£226.60		+£0
Average monthly cash profit	£3.94	(2.5%)	-£0.02
(Sold stocks profit + Dividends - Fees / Months)

Sell value increased by £10 as JLP:Jubilee Metals climbed a little. Will it climb enough to sell for a profit?

It's thinking about going up a bit

If it stays like this I will take about 50 years to break even!

DDDD:4D Pharma announced that they have approached 50 different pharma companies in a bid to sell the company. They are confident there will be enough to pay off all debtors and have something left over for shareholders, but I don't think anyone believes we will get anything like what we paid for the shares back again. I'm still steeling myself for losing the whole lot, so anything we might get back will be a bonus. I'm never going near pharma stocks ever again!

Week 364 Review - Virtually flat week with very little happening

An almost flat week. OPTI:Optibiotix put a slight downer on it, dropping 0.5p, and a few things rallied a little so the widening of deficit between cost and value was reduced to £560, making the gap £78,853 and total portfolio value £104,574.

No big losers this week.

JLP:Jubilee Metals went up 5% of my purchase price which isn't that much in current terms, but at least it's going in the right direction.

CAML:Central Asia Metals won Share of the Week for the 2nd week in a row, so is hopefully on a roll back to fair value. They went up 6% this week and are now 9% up and making £206 potential profit.

Stays just above the injection line

Gradually pulling the trend line flatter, but it won't get flat till we claw back another £50K of losses. More likely that it will take a few more months and by then we'll only need to have clawed back £25K of losses to make it flat.

Here's the ISA and shares portfolio after week 52 of year 7.

			Weekly Change
Cash	£100		+£0
Portfolio cost	£82,912.77		+£0
Portfolio sell value (bid price-commission)	£45,806.40	(-44.8%)	-£452.87
Potential profits	£1,244.55		+£27.00
Yr 7 Dividends	£10,425.77		+£0
Yr 7 Profit from sales	£3,970.12		+£0
Yr 7 projected avg monthly profit	£1,196.22	(32.4%)	-£23.46
Total Dividends	£11,768.92		+£0
Total Profit from sales	£28,094.06		+£0
Average monthly cash profit	£470.72	(12.7%)	-£1.29
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	89%		+0%

The last week of year 7 and a relatively small dip of £452. JLP:Jubilee Metals is still the only share in profit, with nothing else remotely close to breaking even except for the PBX:Probiotix dividend shares which haven't changed price since they floated. The annual profit of 32.4% is nearly all down to the PBX dividend and the way I accounted for it. However, even without that dividend I managed bang on 10%, largely due to selling off most of my JLP:Jubilee Metals holding for between 250 and 300% profit. Long term performance is healthy at 12.7% but would be 9.5% without the dividend. I'd be pleased with that, at least until DDDD:4D Pharma go bust, in which case it would drop to about 6% so I need the divi to mitigate that.

Just above the injection line

Comfortably above the trend line.

The SIPP looks like this after week 348 overall and week 36 of year 7.

			Weekly Change
Cash	£103.73		+£0
Portfolio cost	£98,389.93		+£0
Portfolio sell value (bid price - commission)	£57,793.01	(-41.3%)	-£114.76
Potential profits	£236.72		+£150.64
Yr 7 Dividends	£10,727.13		+£0
Yr 7 Interest	£0.01		+£0
Yr 7 Profit from sales	£275.31		+£0
Yr 7 projected avg monthly profit	£1,309.44	(28.1%)	-£37.41
Total Dividends	£13,931.52		+£0
Total Interest	£0.21		+£0
Total Profit from sales	£23,999.94		+£0
Average monthly cash profit	£460.55	(9.9%)	-£1.32
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	66%		+0%

Potential profits up by £140 thanks to CAML:Central Asia Metals putting on 6% just after I doubled my holding. PLUS:Plus500 also went up 1% to contribute. Lots of small increases elsewhere helped mitigate the drop in OPTI:Optibiotix so value only dropped £114.

Similar to ISA

Only need £20K to flatten the trend line

The trading account looks like this after week 314 overall and week 2 of year 7.

			Weekly Change
Cash	£43.18		+£0
Portfolio cost	£1,877.84		+£0
Portfolio sell value (bid price - commission)	£727.95	(-61.2%)	+£6.95
Potential profits	£0.00		+£0
Year 7 Dividends	£0.00		+£0
Year 7 Profit	£0.00		+£0
Yr 7 projected avg monthly profit	£0.00	(0.0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£226.60		+£0
Average monthly cash profit	£3.96	(2.5%)	-£0.01
(Sold stocks profit + Dividends - Fees / Months)

Small increase in JLP:Jubilee Metals helped lift the gloom on this desperate account, but only by £6.

Best you can say is the drop has stalled.

75% of the account is suspended and only one share active. Hard to see how it could be much worse.

I was hoping for momentum to build with OPTI:Optibiotix as last time we had this sort of optimism we shot up. Looks like a period of consolidation waiting for the next news. Frustrating when you don't know if it's coming in months or days.